灃康公司由留美化學(xué)博士團隊創(chuàng )立。公司秉持開(kāi)拓、創(chuàng )新精神，全力推動(dòng)新技術(shù)、新材料和新藥物的研發(fā)，立志成為全球醫藥研發(fā)領(lǐng)域的佼佼者。引領(lǐng)行業(yè)技術(shù)革新，創(chuàng )造卓越價(jià)值，回報社會(huì )和投資人。主要業(yè)務(wù)包括：新材料開(kāi)發(fā)、原料藥/中間體研發(fā)、技術(shù)開(kāi)發(fā)與轉讓。

Fulkare Company was founded by a team of Ph.D chemists. Embracing a spirit of pioneering and innovation, the company is dedicated to develop new technologies, new materials and new drugs. Fulkare aspires to be a leading innovator in the global pharmaceutical field, driving technology improvement, creating valuble products to society, and delivering returns to our investors. Our core businesses include new material development, API/intermediate R&D, and technology development.